Previous 10 | Next 10 |
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Among biotech stocks, there are several established names that have products in markets and deep pipelines. These companies deliver predictable revenue and earnings, and maybe even a dividend for good measure. This combinat...
The healthcare industry is growing at an unprecedented rate, and healthcare stocks are poised to benefit from this growth. This is large because healthcare companies are developing innovative new treatments and technologies that are transforming the way we care for our health. As a resu...
Summary Harris Associates’ 13F portfolio value decreased from $75.90B to $62.85B this quarter. They increased Amazon.com, Meta Platforms, and Salesforce while reducing Keurig Dr. Pepper, Humana, Regeneron Pharma, CVS Health, Constellation Brands, and General Dynamics. T...
Summary JOET picks large-cap companies with a ranking system based on trend, profitability, and growth. It follows an equal-weight methodology. Aggregate valuation and quality metrics look better than the benchmark. Price history is too short to make a case, but my long-te...
Regeneron to Report Third Quarter 2022 Financial and Operating Results and Host Conference Call and Webcast on November 3, 2022 PR Newswire TARRYTOWN, N.Y. , Oct. 4, 2022 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today annou...
Regeneron Pharmaceuticals (NASDAQ: REGN) , Vertex Pharmaceuticals (NASDAQ: VRTX), and Biogen (NASDAQ: BIIB) are developing remarkable therapies that, instead of merely treating disorders, have the potential to cure them or at least make an impact that no other drug h...
Summary ARKG's objective is compelling and inoffensive, but their current approach to realizing it feels too vague and scattershot. While the larger names in the portfolio do appear to belong, the bulk of the fund is in up-and-coming names, pre-profit, that feel like acquisition i...
Summary Asian markets continue to struggle this year, thanks in large part to the weak China market. The only asset class showing positive performance is volatility. It has been a bumpy ride down this year, with six failed rally attempts. We are now 25.3% below the high water mark...
Regeneron Elects Dr. Craig B. Thompson to Board of Directors PR Newswire Former President and CEO of Memorial Sloan Kettering Cancer Center brings a unique combination of business and scientific leadership, with exceptional experience in immuno-oncology, translational ...
Biotech stocks are stocks of companies that are involved in the research and development of new drugs, medical devices, and other health-related technologies. Biotech investors like these stocks for many reasons, but most importantly because they offer the potential for high growth. The adv...
News, Short Squeeze, Breakout and More Instantly...
Regeneron Pharmaceuticals Inc. Company Name:
REGN Stock Symbol:
NASDAQ Market:
Regeneron Pharmaceuticals Inc. Website:
A look at the top 10 most actives in the United States Qualigen Therapeutics Inc. (QLGN) rose 111.4% to $0.4341 on volume of 412,713,755 shares Maxeon Solar Technologies Ltd. (MAXN) fell 1.3% to $0.2375 on volume of 280,800,277 shares NVIDIA Corporation (NVDA) rose 1.4% to $129.24 on volu...
2024-07-12 11:00:05 ET Trung Huynh from UBS issued a price target of $1,250.00 for REGN on 2024-07-12 10:18:00. The adjusted price target was set to $1,250.00. At the time of the announcement, REGN was trading at $1092.3075. The overall price target consensus is at $902....
A look at the top 10 most actives in the United States Maxeon Solar Technologies Ltd. (MAXN) rose 3.6% to $0.2493 on volume of 118,503,418 shares Qualigen Therapeutics Inc. (QLGN) rose 94.8% to $0.4 on volume of 100,863,101 shares AgriFORCE Growing Systems Ltd. (AGRI) rose 20.0% to $0.098...